Overexpression of PARP is an independent prognostic marker for poor survival in Middle Eastern breast cancer and its inhibition can be enhanced with embelin co-treatment

Abstract excerpt

// Abdul Khalid Siraj 1, * , Poyil Pratheeshkumar 1, * , Sandeep Kumar Parvathareddy 1 , Sasidharan Padmaja Divya 1 , Fouad Al-Dayel 2 , Asma Tulbah 2 , Dahish Ajarim 3 and Khawla S. Al-Kuraya 1 1 Human Cancer Genomic Research, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia 2 Department of Pathology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia 3 Department...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cell death mechanisms and regulation
• Share to DNA Repair Mechanisms
• Share to PARP inhibition in cancer therapy